p-Tolylacetic acid → HCID 70976227, compound

HRID 535562Notes

Reaction equation

HRID 535562 reaction equation
[NH2:1][N:2]1[N:11]=[C:10]([N:12]2[CH2:17][CH2:16][O:15][CH2:14][CH2:13]2)[C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[C:3]1=[O:18].[CH3:19][C:20]1[CH:25]=[CH:24][C:23]([CH2:26][C:27](O)=[O:28])=[CH:22][CH:21]=1>>[CH3:19][C:20]1[CH:25]=[CH:24][C:23]([CH2:26][C:27]([NH:1][N:2]2[N:11]=[C:10]([N:12]3[CH2:17][CH2:16][O:15][CH2:14][CH2:13]3)[C:9]3[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=3)[C:3]2=[O:18])=[O:28])=[CH:22][CH:21]=1

Participants

3

Reactant 2

HCID 248474p-Tolylacetic acidHCID 709761042-amino-4-morpholinophthalazin-1(2H)-one

Product 1

HCID 70976227HCID 70976227, compound

Procedure

The product of Example 1B and 2-(4-methylphenyl)acetic acid were treated using a method similar to that described in Example 111 to give the title compound. 1H NMR (500 MHz, DMSO-d6/D2O) δ 8.30 (dd, J=7.9, 0.8, 1H), 8.04-8.02 (m, 1H), 8.01-7.96 (m, 1H), 7.94-7.88 (m, 1H), 7.26 (d, J=8.0, 2H), 7.16 (d, J=7.9, 2H), 3.87-3.78 (m, 4H), 3.61 (s, 2H), 3.13-3.05 (m, 4H), 2.30 (s, 3H); MS (ESI+) M/Z 379 (M+H)+.

Sources & evidence

ORD record
ord-748a51cd761c486eaf5fe9e8ed7c2083
Source dataset
uspto-grants-2014_10
Patent number
US08859549B2

Reaction notes

Loading…